Quantcast

Latest Artificial pancreas Stories

2014-08-12 12:28:18

Company's Network and Technology Enable Trial of Artificial Pancreas in California NEW YORK, Aug. 12, 2014 /PRNewswire/ -- Kids and teens with Type 1 diabetes are swimming, rock climbing, hiking and playing various field sports in the redwoods of the Santa Cruz Mountains - all while testing a device that automatically measures their blood sugar and determines how much insulin they'll need. Using Verizon's network technology, campers aged 7 to 17 are participating in a clinical...

2014-08-04 12:35:07

LONDON, Aug. 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: U.S. Glucose Testing Markets http://www.reportbuyer.com/pharma_healthcare/diagnostics/u_s_glucose_testing_markets.html U.S. glucose testing is undergoing a significant transition, driven by new analytical technologies and developments in diabetes treatment. Although the blood glucose testing segment of the in vitro diagnostics (IVD) industry is mature, several segments of the market, such...

2014-08-04 12:34:38

LONDON, Aug. 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: World Glucose Self-Testing Markets http://www.reportbuyer.com/pharma_healthcare/diseases/diabetes/world_glucose_self_testing_markets.html The worldwide incidence of diabetes is dramatically increasing, and it is estimated that 439 million people will have developed the disease by 2030. As such, the global market for blood glucose self-testing products is undergoing a significant transition...

type-1 diabetes
2014-08-01 02:00:43

Susan Gammon, Ph.D., Sanford-Burnham Medical Research Institute A new study by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) has found that a peptide called caerulein can convert existing cells in the pancreas into those cells destroyed in type 1 diabetes—insulin-producing beta cells. The study, published online July 31 in Cell Death and Disease, suggests a new approach to treating the estimated 3 million people in the U.S., and over 300 million worldwide,...

2014-07-30 16:28:55

-- JDRF Calls for CGM Medicare Coverage to Help Improve Health Outcomes Among Seniors with T1D and Advance an Artificial Pancreas -- WASHINGTON, July 30, 2014 /PRNewswire-USNewswire/ -- Today U.S. Senators Susan Collins (R-ME) and Jeanne Shaheen (D-NH), Co-chairs of the Senate Diabetes Caucus, introduced legislation to ensure that seniors with type 1 diabetes (T1D) who are Medicare eligible have access to continuous glucose monitors (CGM) as prescribed by their physicians. The...

2014-07-21 12:24:39

Passionate volunteer will now lead organization toward life-changing treatments on path to ultimate cure for type one diabetes (T1D) NEW YORK, July 21, 2014 /PRNewswire/ -- JDRF's International Board of Directors (IBOD) announced today the appointment of Derek Rapp, currently Vice Chair of the JDRF International Board of Directors, as its new President and CEO. http://photos.prnewswire.com/prnvar/20140721/128866 Rapp replaces Jeffrey Brewer who recently left his role as JDRF...

2014-07-17 16:25:37

NEW YORK, July 17, 2014 /PRNewswire/ -- JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research announced today ViaCyte, Inc., a leading regenerative medicine company, has filed an Investigational New Drug application (IND) with the U.S. Food and Drug Administration (FDA) seeking to initiate a Phase 1/2 clinical trial in patients with type 1 diabetes. The trial would evaluate the safety and efficacy of the VC-01(TM) product candidate, a stem...

2014-06-20 23:06:47

ResearchMoz.us includes new market research report "Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers" to its huge collection of research reports. Albany, NY (PRWEB) June 20, 2014 The report provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment’s...

2014-06-16 18:01:02

Tonic Life Communications USA Presented at the American Diabetes Association Scientific Sessions Animas Corporation today shared encouraging results from its predictive hypoglycemia-minimizing algorithm in development. Data from a clinical feasibility study demonstrated that the algorithm was capable of helping maintain glucose above hypoglycemic levels an average of 99.1 percent of the time for the 12 participants investigated, all of whom were adults with type 1 diabetes. The study...

Diabetes Patients May Get Better Results With Bionic Pancreas
2014-06-16 10:23:47

Brett Smith for redOrbit.com - Your Universe Online A team of Massachusetts researchers working on a bionic pancreas were able to show that their device could maintain blood glucose levels consistently within the normal range, with fewer dangerous lows or highs, according to a paper published in the New England Journal of Medicine. The team said their device could make a massive difference in the lives of countless individuals coping with Type 1 diabetes. Conventional care for this kind...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related